Leebeek FW - Search Results

1

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.

Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Lisman T, et al. Among authors: leebeek fw. Hepatology. 2006 Jul;44(1):53-61. doi: 10.1002/hep.21231. Hepatology. 2006. PMID: 16799972

2

Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation.

Lisman T, Leebeek FW, Meijer K, Van Der Meer J, Nieuwenhuis HK, De Groot PG. Lisman T, et al. Among authors: leebeek fw. Hepatology. 2002 Mar;35(3):616-21. doi: 10.1053/jhep.2002.31771. Hepatology. 2002. PMID: 11870375

3

Haemostatic abnormalities in patients with liver disease.

Lisman T, Leebeek FW, de Groot PG. Lisman T, et al. Among authors: leebeek fw. J Hepatol. 2002 Aug;37(2):280-7. doi: 10.1016/s0168-8278(02)00199-x. J Hepatol. 2002. PMID: 12127437 Review. No abstract available.

4

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.

Brouwers GJ, Leebeek FW, Tanck MW, Wouter Jukema J, Kluft C, de Maat MP. Brouwers GJ, et al. Among authors: leebeek fw. Thromb Haemost. 2003 Jul;90(1):92-100. Thromb Haemost. 2003. PMID: 12876631

5

In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease.

Ver Elst KM, van Vliet HD, Kappers-Klunne MC, Leebeek FW. Ver Elst KM, et al. Among authors: leebeek fw. Thromb Haemost. 2004 Jul;92(1):67-74. doi: 10.1160/TH04-02-0107. Thromb Haemost. 2004. PMID: 15213847

6

Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis.

van Marion AM, Auwerda JJ, Minnema MC, van Oosterom R, Adelmeijer J, de Groot PG, Leebeek FW, Sonneveld P, Lokhorst HM, Lisman T. van Marion AM, et al. Among authors: leebeek fw. Thromb Haemost. 2005 Dec;94(6):1341-3. doi: 10.1160/th05-06-1341. Thromb Haemost. 2005. PMID: 16411420 Clinical Trial. No abstract available.

7

High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability.

Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gómez García EB, Dippel DW, Leebeek FW. Bongers TN, et al. Among authors: leebeek fw. Stroke. 2006 Nov;37(11):2672-7. doi: 10.1161/01.STR.0000244767.39962.f7. Epub 2006 Sep 21. Stroke. 2006. PMID: 16990571

8

Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels.

van Schooten CJ, Denis CV, Lisman T, Eikenboom JC, Leebeek FW, Goudemand J, Fressinaud E, van den Berg HM, de Groot PG, Lenting PJ. van Schooten CJ, et al. Among authors: leebeek fw. Blood. 2007 Mar 15;109(6):2430-7. doi: 10.1182/blood-2006-06-032706. Epub 2006 Nov 7. Blood. 2007. PMID: 17090649 Free article.

9

JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis?

Janssen HL, Leebeek FW. Janssen HL, et al. Among authors: leebeek fw. Hepatology. 2006 Dec;44(6):1391-3. doi: 10.1002/hep.21489. Hepatology. 2006. PMID: 17133464 No abstract available.

10

Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome.

Smalberg JH, Darwish Murad S, Braakman E, Valk PJ, Janssen HL, Leebeek FW. Smalberg JH, et al. Among authors: leebeek fw. Haematologica. 2006 Dec;91(12):1712-3. Haematologica. 2006. PMID: 17145613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters